Mycobacterium chelonae complex bacteremia from a post-renal transplant patient: Case report and literature review

Japanese Journal of Infectious Diseases

Volumn 63, Issue 1, 2010, Pages 61-64

  Somily, Ali Mohammed ^a   Al Anazi, Awadh Raheel ^b   Babay, Hanan Ahmed ^a   Al Aska, Abdulkarim Ibraheem ^b   Al Hedaithy, Mugbil Ahmed ^b   Al Hamoudi, Waleed Khalid ^b   Al Boukai, Ahmad Amer ^b   Sabri, Mohammed Sarwar ^a   AlThawadi, Sahar Isa ^c   Kambal, Abdelmageed Mohamed ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; ETHAMBUTOL; PENICILLIN G; PIPERACILLIN; RIFAMPICIN; TAZOBACTAM; TETRACYCLINE; VANCOMYCIN;

ABDOMINAL ABSCESS; ACID FAST BACTERIUM; ADULT; ANTIMICROBIAL THERAPY; ARTERIOVENOUS FISTULA; ARTICLE; BACTEREMIA; BACTERIUM COLONY; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CASE REPORT; CATHETERIZATION; DIALYSIS; FEMALE; FEVER; GRAM POSITIVE BACTERIUM; GRAM STAINING; HEMODYNAMICS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MORBIDITY; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; PERITONEAL FLUID; SEPSIS; SEPTICEMIA; TREATMENT FAILURE;

ABDOMINAL ABSCESS; ADULT; ANTITUBERCULAR AGENTS; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; MICROSCOPY; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; STAINING AND LABELING; TIME FACTORS;

EID: 76649142062     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Barbra, A., Brown-Elliott, R.J. and Wallace, R., Jr. (2005): Infections caused by nontuberculous mycobacteria. p. 2909-2914. In G.L. Mandell, J. Bennett and R.E. Dolin (ed), Principles and Practice of Infectious Diseases. Elsevier Churchill Livingstone.
2. Runyon, E.H. (1959): Anonymous mycobacteria in pulmonary disease. Med. Clin. North Am., 43, 273-290.
3. Runyon, E.H. (1970): Identification of mycobacterial pathogens using colony characteristics. Am. J. Clin. Pathol., 54, 578-586.
4. Hall-Stoodley, L. and Lappin-Scott, H. (1998): Biofilm formation by the rapidly growing mycobacterial species Mycobacterium fortuitum. FEMS Microbiol. Lett., 168, 77-84.
5. Hall-Stoodley, L. and Stoodley, P. (2005): Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol., 13, 7-10.
6. Schulze-Robbecke, R. and Buchholtz, K. (1992): Heat susceptibility of aquatic mycobacteria. Appl. Environ. Microbiol., 58, 1869-1873.
7. De Groote, M.A. and Huitt, G. (2006): Infections due to rapidly growing mycobacteria. Clin. Infect. Dis., 42, 1756-1763.
8. Phillips, M.S. and Von Reyn, C.F. (2001): Nosocomial infections due to mycobacteria. Clin. Infect. Dis., 33, 1365-1374.
9. Vera, G. and Lew, S.Q. (1999): Mycobacterium fortuitum peritonitis in two patients receiving continuous ambulatory peritoneal dialysis. Am. J. Nephrol., 19, 586-589.
10. Soriano, F., Rodriguez-Tudela, J.L., Gómez-Garcés, J.L., et al. (1989): Two possibly related cases of Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis. Eur. J. Clin. Microbiol. Infect. Dis., 8, 895-897.
11. Band, J.D., Ward, J.I., Fraser, D.W., et al. (1982): Peritonitis due to a Mycobacterium chelonae-like organism associated with intermittent chronic peritoneal dialysis. J. Infect. Dis., 145, 9-17.
12. Bolan, G., Reingold, A.L., Carson, L.A., et al. (1985): Infections with Mycobacterium chelonae in patients receiving dialysis and using processed hemodialyzers. J. Infect. Dis., 152, 1013-1019.
13. Hoffman, P.C., Fraser, D.W., Robicsek, F., et al. (1981): Two outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex. J. Infect. Dis., 143, 533-542.
14. Kuritsky, J.N., Bullen, M.G., Broome, C.V., et al. (1983): Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann. Intern. Med., 98, 938-939.
15. Robicsek, F., Daugherty, H.K., Cook, J.W., et al. (1978): Mycobacterium fortuitum epidemics after open-heart surgery. J. Thorac. Cardiovasc. Surg., 75, 91-96.
16. Szabo, I. and Sarkozi, K. (1980): Mycobacterium chelonae endemy [sic] after heart surgery with fatal consequences. Am. Rev. Respir. Dis., 121, 607.
17. Levy, C., Curtin, J.A., Watkins, A., et al. (1977): Mycobacterium chelonae infection of porcine heart valves. N. Engl. J. Med., 297, 667-668.
18. Laskowski, L.F., Marr, J.J., Spernoga, J.F., et al. (1977): Fastidious mycobacteria grown from porcine prosthetic-heart-valve cultures. N. Engl. J. Med., 297, 101-102.
19. Centers for Disease and Control (1978): Follow-up on mycobacterial contamination of porcine heart valve prosthesis - United States. Morbid. Mortal. Wkly. Rep., 27, 927-928.
20. Engelhardt, E., Feldmann, R., Skaria, A., et al. (1996): Postoperative infection with Mycobacterium chelonae. Hautarzt, 47, 863-866.
21. Soto, L.E., Bobadilla, M., Villalobos, Y., et al. (1991): Post-surgical nasal cellulitis outbreak due to Mycobacterium chelonae. J. Hosp. Infect., 19, 99-106.
22. Wallace, R.J., Jr., Steele, L.C., Labidi, A., et al. (1989): Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states. J. Infect. Dis., 160, 281-288.
23. Clegg, H.W., Foster, M.T., Sanders, W.E., et al. (1983): Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J. Infect. Dis., 147, 427-433.
24. Juang, Y.C., Wang, L.S., Chen, C.H., et al. (1989): Mycobacterium fortuitum mastitis following augmentation mammaplasty: report of a case. Taiwan Yi Xue Hui Za Zhi., 88, 278-281 (text in Chinese).
25. Toranto, I.R. and Malow, J.B. (1980): Atypical mycobacteria periprosthetic infections - diagnosis and treatment. Plast. Reconstr. Surg., 66, 226-228
26. Buckley, R., Cobb, M.W., Ghurani, S., et al. (1997): Mycobacterium fortuitum infection occurring after a punch biopsy procedure. Pediatr. Dermatol., 14, 290-292.
27. Saluja, A., Peters, N.T., Lowe, L., et al. (1997): A surgical wound infection due to Mycobacterium chelonae successfully treated with clarithromycin. Dermatol. Surg., 23, 539-543.
28. Rajini, M., Prasad, S.R., Reddy, R.R., et al. (2007): Postoperative infection of laparoscopic surgery wound due to Mycobacterium chelonae. Indian J. Med. Microbiol., 25, 163-165.
29. Kiely, J.L., Sheehan, S., Cryan, B., et al. (1995): Isolation of Mycobacterium chelonae in a bronchoscopy unit and its subsequent eradication. Tuber. Lung Dis., 76, 163-167.
30. Gubler, J.G., Salfinger, M. and Von Graevenitz, A. (1992): Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope cleaning machine. Report of an outbreak and review of the literature. Chest, 101, 1245-1249.
31. Wang, H.C., Liaw, Y.S., Yang, P.C., et al. (1995): A pseudoepidemic of Mycobacterium chelonae infection caused by contamination of a fibreoptic bronchoscope suction channel. Eur. Respir. J., 8, 1259-1262.
32. Brown, N.M., Hellyar, E.A., Harvey, J.E., et al. (1993): Mycobacterial contamination of fibreoptic bronchoscopes. Thorax, 48, 1283-1285.
33. Dearnaley, J.N. (1976): Mycobacteria contaminating histological sections. J. Clin. Pathol., 29, 568.
34. Patel, R. and Paya, C.V. (1997): Infections in solid-organ transplant recipients. Clin. Microbiol. Rev., 10, 86-124.
35. Chetchotisakd, P., Kiertiburanakul, S., Mootsikapun, P., et al. (2007): Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin. Infect. Dis., 45, 421-427.
36. Swenson, J., Richard, J., Wallace, J.R., et al. (1985): Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob. Agents Chemother., 28, 807-811.
37. Fernandez-Roblas, R., Esteban, J., Cabria, F., et al. (2000): In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. Antimicrob. Agents Chemother., 44, 181-182.
38. Wallace, J.R., Jr., Brown-Elliott, B.A., Ward, S.C., et al. (2001): Activities of linezolid against rapidly growing mycobacteria. Antimicrob. Agents Chemother., 45, 764-767.
39. Brown-Elliott, B.A., Wallace, J.R., Jr., Crist, C.J., et al. (2002): Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria. Antimicrob. Agents Chemother., 46, 3283-3285.
40. Woods, G.L., Bergmann, J.C., Witebsky, F.G., et al. (2000): Reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J. Clin. Microbiol., 38, 656-661.
41. Clinical and Laboratory Standards Institute (2008): Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; tentative standard. document M24-A, 23, 25-31. Clinical and Laboratory Standards Institute,Wayne, Pa.
42. Woods, G.L. (2000): Susceptibility testing for mycobacteria. Clin. Infect. Dis., 31, 1209-1215.
43. Daley, C.L. and Griffith, D.E. (2002): Pulmonary disease caused by rapidly growing mycobacteria. Clin. Chest Med., 23, 623-632.
44. Vemulapalli, R.K., Cantey, J.R., Steed, L.L., et al. (2001): Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: case report and literature review. J. Infect., 43, 163-168.
45. Wallace, J.R., Jr., Tanner, D., Brennan, P.J., et al. (1993). Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann. Intern. Med., 119, 482-486.
46. Wallace, J.R., Jr., Swenson, J.-M., Silcox, V.A., et al. (1985): Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonae on the basis of in vitro susceptibilities. J. Infect. Dis., 152, 500-514.
47. Jackson, J., Leggett, J.E., Wilson, D., et al. (1996): Mycobacterium gordonae in fibroptic bronchoscope. Am. J. Infect. Control, 24, 19-23.
48. Nicholson, G., Hudson, R.A., Chadwick, M.V., et al. (1995): The efficacy of the disinfection of bronchoscopes contaminated in vitro with Mycobacterium tuberculosis and Mycobacterium avium-intracellulare in sputum: a comparision of Sactimed-I-Sinald and glutaraldehyde. J. Hosp. Infect., 29, 257-264.
49. Middleton, A.M., Chadwick, M.V. and Gaya, H. (1997): Disinfection of brochoscpes, contaminated in vitro with Mycobacterium tuberculosis, Mycobacterium avium-intracellulare and Mycobacterium chelonae in sputum, using stabilized, buffered peracetic acid solution ('Nu-Cidex'). J. Hosp. Infect., 37, 137-143.
50. Miyamoto, M., Yamaguchi, Y. and Sasatsu, M. (2000): Disinfectant effects of hot water, ultraviolet, silver ions and chlorine on strains of Legionella and nontuberculous mycobacteria. Microbios, 101, 7-13.
51. Griffith, D.E., Aksamit, T., Brown-Elliott, B.A., et al. (2007): An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med., 175, 167-416.